Assembly Biosciences Inc.(ASMB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASMB Assembly Biosciences Inc.

休市中 07-02 16:00:00 EDT

27.74

+1.05

+3.93%

盘后27.39

-0.35-1.26%

17:32 EDT

最高27.77	最低26.41	成交量19.93万
今开26.75	昨收26.69	日振幅5.10%
总市值5.34亿	流通市值3.02亿	总股本1,925万
成交额538.63万	换手率1.83%	流通股本1,088万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ASMB","market":"US","secType":"STK","nameCN":"Assembly Biosciences Inc.","latestPrice":27.74,"timestamp":1783022400000,"preClose":26.69,"halted":0,"volume":199257,"hourTrading":{"tag":"盘后","latestPrice":27.39,"preClose":27.74,"latestTime":"17:32 EDT","volume":673,"amount":18562.92,"timestamp":1783027955875,"change":-0.35,"changeRate":-0.012617,"amplitude":0.012617},"delay":0,"changeRate":0.039340576995129155,"floatShares":10878800,"shares":19251000,"eps":-1.2901,"marketStatus":"休市中","change":1.05,"latestTime":"07-02 16:00:00 EDT","open":26.75,"high":27.77,"low":26.41,"amount":5386306.058178,"amplitude":0.050955,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.2901,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1292562000000,"exchange":"NASDAQ","adjPreClose":26.69,"postHourTrading":{"tag":"盘后","latestPrice":27.39,"preClose":27.74,"latestTime":"17:32 EDT","volume":673,"amount":18562.92,"timestamp":1783027955875,"change":-0.35,"changeRate":-0.012617,"amplitude":0.012617},"volumeRatio":0.3907067414839451,"impliedVol":0.8279,"impliedVolPercentile":0.446},"requestUrl":"/m/hq/s/ASMB","defaultTab":"news","newsList":[{"id":"1140272043","title":"Assembly Biosciences 定价发行340万股及41.5万份预融资权证","url":"https://stock-news.laohu8.com/highlight/detail?id=1140272043","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140272043?lang=zh_cn&edition=full","pubTime":"2026-05-22 19:07","pubTimestamp":1779448022,"startTime":"0","endTime":"0","summary":"Assembly Biosciences Inc. 已确定其公开发行定价。公司将以每股26.50美元的价格发行340万股普通股。同时，还将发行41.5万份预融资权证，每份定价为26.499美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117620457","title":"Assembly Biosciences公布普通股及预融资权证发行定价，融资规模达1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117620457","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117620457?lang=zh_cn&edition=full","pubTime":"2026-05-22 19:06","pubTimestamp":1779448014,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司近日公布了其普通股及预融资权证的发行定价细节，此次融资总额预计将达到1亿美元。这一举措旨在为公司后续的研发与运营活动提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174745774","title":"Assembly Biosciences计划于2026年第四季度启动Abi-6250治疗HDV的二期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1174745774","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174745774?lang=zh_cn&edition=full","pubTime":"2026-05-22 19:01","pubTimestamp":1779447683,"startTime":"0","endTime":"0","summary":"Assembly Biosciences Inc. 宣布，计划在2026年第四季度启动其候选药物Abi-6250用于治疗丁型肝炎病毒（HDV）感染的二期临床研究。这一举措标志着该公司在开发针对这一严重肝脏疾病的新型疗法方面迈出了关键一步。HDV感染被认为是病毒性肝炎中最严重的一种形式，目前治疗选择极为有限，因此Abi-6250的临床进展备受关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131717472","title":"Assembly Biosciences宣布将Abi-6250临床开发扩展至胆汁淤积性肝病领域","url":"https://stock-news.laohu8.com/highlight/detail?id=1131717472","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131717472?lang=zh_cn&edition=full","pubTime":"2026-05-22 19:01","pubTimestamp":1779447676,"startTime":"0","endTime":"0","summary":"Assembly Biosciences宣布，其正在将Abi-6250的临床开发项目拓展至针对胆汁淤积性肝病的治疗研究。这一战略扩展标志着该公司在肝病治疗领域迈出了新的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616721223","title":"Assembly Biosciences, Inc.盘中异动 快速下挫5.12%报28.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616721223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616721223?lang=zh_cn&edition=full","pubTime":"2026-03-03 23:30","pubTimestamp":1772551807,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日23时30分，Assembly Biosciences, Inc.股票出现波动，股价快速下跌5.12%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.63%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。Assembly 发现了几种新型核心蛋白变构调节剂，它们是直接靶向和变构调节 HBV 核心蛋白的小分子。大部分收入来自 HBV 治愈计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030323300797a7e296&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030323300797a7e296&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609243537","title":"Assembly Biosciences, Inc.盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609243537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609243537?lang=zh_cn&edition=full","pubTime":"2026-02-06 03:32","pubTimestamp":1770319953,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日03时32分，Assembly Biosciences, Inc.股票出现波动，股价急速下跌5.73%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。Assembly 发现了几种新型核心蛋白变构调节剂，它们是直接靶向和变构调节 HBV 核心蛋白的小分子。大部分收入来自 HBV 治愈计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206033233a4815712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206033233a4815712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177566900","title":"吉利德科学行使许可选项，以获得Assembly Biosciences针对复发性生殖器疱疹的解旋酶-启动酶抑制剂项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1177566900","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177566900?lang=zh_cn&edition=full","pubTime":"2025-12-22 21:03","pubTimestamp":1766408625,"startTime":"0","endTime":"0","summary":"吉利德科学行使许可选项，以获得Assembly Biosciences针对复发性生殖器疱疹的解旋酶-启动酶抑制剂项目","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASMB","LU0823416689.USD","IE00BSNM7G36.USD","BK4578","IE00B3T34201.USD","SG9999015945.SGD","LU1430594728.SGD","LU2089984988.USD","LU2087621335.USD","BK4550","LU1674673691.USD","LU2468319806.SGD","LU1571399168.USD","LU0882574055.USD","BK4588","LU0109394709.USD","LU0234570918.USD","LU0889565916.HKD","BK4568","IE0002270589.USD","BK4139","BK4566","GILD","LU1066051498.USD","LU1674673428.USD","LU0320765992.SGD","LU1066053197.SGD","LU0114720955.EUR","BK4532","IE00B19Z3B42.SGD","SG9999015986.USD","SG9999015978.USD","IE00BZ1G4Q59.USD","LU1778281490.HKD","LU0289739699.SGD","BK4585","IE00B19Z3581.USD","LU2324357040.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU0058720904.USD","BK4583","LU1585245621.USD","LU1839511570.USD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518272511","title":"Assembly Biosciences, Inc.盘中异动 股价大涨6.92%报11.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518272511?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:04","pubTimestamp":1741615478,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时04分，Assembly Biosciences, Inc.股票出现异动，股价快速上涨6.92%。截至发稿，该股报11.89美元/股，成交量1524股，换手率0.02%，振幅0.00%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为678.83%、351.08%、95.83%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Pmgc Holdings Inc.，振幅分别为41.36%、40.24%、32.14%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220439a26a3159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220439a26a3159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517394408","title":"Assembly Biosciences, Inc.盘中异动 股价大跌6.03%报11.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517394408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517394408?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:39","pubTimestamp":1741192746,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时39分，Assembly Biosciences, Inc.股票出现波动，股价大幅下挫6.03%。截至发稿，该股报11.23美元/股，成交量1.2352万股，换手率0.19%，振幅5.36%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003907989d631e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003907989d631e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517609917","title":"Assembly Biosciences, Inc.盘中异动 快速下挫5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517609917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517609917?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:30","pubTimestamp":1741105804,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时30分，Assembly Biosciences, Inc.股票出现波动，股价快速跳水5.40%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1197.32%、1164.83%、794.13%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Celularity Inc C/Wts 16/07/2026 ，振幅分别为117.24%、66.67%、66.02%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305003004989bc9f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305003004989bc9f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514854237","title":"Assembly Biosciences, Inc.盘中异动 股价大涨5.27%报12.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514854237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514854237?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:21","pubTimestamp":1740583283,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时21分，Assembly Biosciences, Inc.股票出现波动，股价快速上涨5.27%。截至发稿，该股报12.99美元/股，成交量4649股，换手率0.07%，振幅4.71%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Enveric Biosciences, Inc.、Athira Pharma, Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5069.39%、182.02%、171.15%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Organovo Holdings, Inc.，振幅分别为161.02%、39.47%、33.94%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226232123a25502a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226232123a25502a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514766097","title":"Assembly Biosciences, Inc.盘中异动 临近午盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514766097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514766097?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:34","pubTimestamp":1740414884,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时34分，Assembly Biosciences, Inc.股票出现波动，股价快速拉升5.26%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Pepgen Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为257.05%、113.80%、34.78%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Celularity Inc C/Wts 16/07/2026 ，振幅分别为162.04%、55.69%、54.86%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003445962eb442&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003445962eb442&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512169460","title":"Assembly Biosciences, Inc.盘中异动 股价大跌5.15%报12.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169460?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:48","pubTimestamp":1739890088,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时48分，Assembly Biosciences, Inc.股票出现波动，股价急速下跌5.15%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Solid Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为311.05%、119.24%、90.21%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.，振幅分别为41.79%、34.04%、26.83%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224809abd3b2eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224809abd3b2eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511696917","title":"Assembly Biosciences, Inc.盘中异动 股价大涨5.13%报12.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696917?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:38","pubTimestamp":1739543919,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时38分，Assembly Biosciences, Inc.股票出现波动，股价急速上涨5.13%。截至发稿，该股报12.84美元/股，成交量6886股，换手率0.11%，振幅2.84%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Os Therapies Incorporated涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1320.81%、394.02%、392.51%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为49.61%、31.35%、27.00%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223839a24602d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223839a24602d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507067339","title":"Assembly Biosciences, Inc.盘中异动 临近午盘股价大涨5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507067339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507067339?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:35","pubTimestamp":1738254902,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时35分，Assembly Biosciences, Inc.股票出现异动，股价急速拉升5.84%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1656.40%、238.81%、214.56%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为65.98%、61.86%、56.41%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310035039876bff3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310035039876bff3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506453585","title":"Assembly Biosciences, Inc.盘中异动 急速下跌6.09%报13.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506453585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506453585?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:24","pubTimestamp":1738002259,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时24分，Assembly Biosciences, Inc.股票出现异动，股价急速下跌6.09%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2150.21%、995.56%、256.71%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.60%、99.77%、65.16%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280224199874d2b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280224199874d2b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503571155","title":"Assembly Biosciences, Inc.盘中异动 早盘快速拉升5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503571155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503571155?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:35","pubTimestamp":1736865306,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时35分，Assembly Biosciences, Inc.股票出现异动，股价急速拉升5.64%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Eterna Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Eterna Therapeutics Inc.、Azitra Inc、Silo Pharma, Inc.较为活跃，换手率分别为127.30%、58.86%、46.21%，振幅较大的相关个股有Eterna Therapeutics Inc.、Fate Therapeutics, Inc.、Lexaria Bioscience Corp.，振幅分别为43.88%、20.93%、20.87%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223506abaaada6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223506abaaada6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503582098","title":"Assembly Biosciences, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503582098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503582098?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:15","pubTimestamp":1736784917,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时15分，Assembly Biosciences, Inc.股票出现波动，股价大幅跳水5.06%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为11468.45%、6233.32%、425.33%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、216.61%、143.09%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140015179602654a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140015179602654a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502987938","title":"Assembly Biosciences, Inc.盘中异动 急速跳水5.55%报16.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502987938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502987938?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:12","pubTimestamp":1736521936,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时12分，Assembly Biosciences, Inc.股票出现波动，股价快速下挫5.55%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.33%。其相关个股中，Conduit Pharmaceuticals Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Precision Biosciences, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1102.08%、402.16%、199.77%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为85.00%、41.78%、37.29%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023121695ff776c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023121695ff776c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502083575","title":"Assembly Biosciences, Inc.盘中异动 急速跳水5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502083575?lang=zh_cn&edition=full","pubTime":"2025-01-09 04:55","pubTimestamp":1736369702,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日04时55分，Assembly Biosciences, Inc.股票出现波动，股价大幅下跌5.53%。Assembly Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、Hoth Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为3653.10%、893.18%、629.50%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、156.87%、89.00%。Assembly Biosciences, Inc.公司简介：Assembly Biosciences Inc 是一家临床阶段的生物技术公司。其大部分收入来自HBV治愈项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109045502985fb29e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109045502985fb29e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASMB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.assemblybio.com","stockEarnings":[{"period":"1week","weight":0.1434},{"period":"1month","weight":0.1327},{"period":"3month","weight":-0.0438},{"period":"6month","weight":-0.178},{"period":"1year","weight":0.5158},{"period":"ytd","weight":-0.1844}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Assembly Biosciences, Inc.于2005年10月7日在特拉华州注册成立，于2007年4月开始运营。该公司是一家生物制药公司，正在推进临床候选药物，这些候选药物有可能改善全球数百万慢性乙型肝炎病毒（HBV）感染者的生活，是一个针对与2型单纯疱疹病毒（HSV-2）感染相关的高复发生殖器疱疹的早期开发项目，研究项目的重点是发现新型抗病毒药物来治疗破坏性病毒性疾病，包括德尔塔型肝炎病毒（HDV）和移植相关疱疹病毒。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.00316},{"month":2,"riseRate":0.5,"avgChangeRate":0.044},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.043561},{"month":4,"riseRate":0.416667,"avgChangeRate":0.009812},{"month":5,"riseRate":0.583333,"avgChangeRate":0.055877},{"month":6,"riseRate":0.416667,"avgChangeRate":0.040197},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.017806},{"month":8,"riseRate":0.5,"avgChangeRate":0.044961},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.041895},{"month":10,"riseRate":0.416667,"avgChangeRate":0.101588},{"month":11,"riseRate":0.5,"avgChangeRate":-0.025648},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.020098}],"exchange":"NASDAQ","name":"Assembly Biosciences Inc.","nameEN":"Assembly Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Assembly Biosciences Inc.(ASMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Assembly Biosciences Inc.(ASMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Assembly Biosciences Inc.,ASMB,Assembly Biosciences Inc.股票,Assembly Biosciences Inc.股票老虎,Assembly Biosciences Inc.股票老虎国际,Assembly Biosciences Inc.行情,Assembly Biosciences Inc.股票行情,Assembly Biosciences Inc.股价,Assembly Biosciences Inc.股市,Assembly Biosciences Inc.股票价格,Assembly Biosciences Inc.股票交易,Assembly Biosciences Inc.股票购买,Assembly Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Assembly Biosciences Inc.(ASMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Assembly Biosciences Inc.(ASMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}